FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

Don't miss out on the headlines from Lifestyle. Followed categories will be added to My News. The study, the biggest of its ...

A woman who started a prematurity awareness day after her twin grandchildren were born 15 weeks early is set to host the ...

FLQ-101 is still an investigational medicine and has not yet been approved by regulatory authorities. "FDA grants fast track ...

Oxygen has been identified as a key element in the delay in retinal maturation and in the development of ROP. Vascular endothelial growth factor (VEGF) is an oxygen-mediated factor that is ...

Oak Hill Bio and Chiesi Group have enrolled the first European patient in a Phase IIb clinical study for their collaborative ...

Con Brio Cares, a local non-profit organisation is reaching out to the community in search of donations to support families ...

Open your heart this World Prematurity Day and help Con Brio Cares put together their care packs. Con Brio Cares seeks ...

Absolutely. The smaller and more pre-term a baby is at birth, the greater their chance of having retinopathy of prematurity (ROP). Most people have had an eye problem. Some are minor and go away ...